142 related articles for article (PubMed ID: 26782388)
1. Influence of vascular endothelial growth factor and alpha-fetoprotein on hepatocellular carcinoma.
Yvamoto EY; Ferreira RF; Nogueira V; Pinhe MA; Tenani GD; Andrade JG; Baitello ME; Gregório ML; Fucuta PS; Silva RF; Souza DR; Silva RC
Genet Mol Res; 2015 Dec; 14(4):17453-62. PubMed ID: 26782388
[TBL] [Abstract][Full Text] [Related]
2. Influence of hepatitis C virus infection on circulating levels of sICAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC.
Helaly GF; Abou Shamaa LA
Egypt J Immunol; 2006; 13(1):27-38. PubMed ID: 17974148
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
4. Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma.
Mukozu T; Nagai H; Matsui D; Kanekawa T; Sumino Y
Anticancer Res; 2013 Mar; 33(3):1013-21. PubMed ID: 23482775
[TBL] [Abstract][Full Text] [Related]
5. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
[TBL] [Abstract][Full Text] [Related]
6. The role of chemokine CC ligand 20 in patients with liver cirrhosis and hepatocellular carcinoma.
Soliman HH; Nagy H; Kotb N; Alm El-Din MA
Int J Biol Markers; 2012 Jul; 27(2):e125-31. PubMed ID: 22388957
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
Motawi TK; Shaker OG; Ismail MF; Sayed NH
Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
[TBL] [Abstract][Full Text] [Related]
8. Association of genetic variants in the interleukin-18 gene promoter with risk of hepatocellular carcinoma and metastasis in patients with hepatitis C virus infection.
Bakr NM; Awad A; A Moustafa E
IUBMB Life; 2018 Feb; 70(2):165-174. PubMed ID: 29341496
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of transforming growth factor alpha and vascular endothelial growth factor in diagnosis of hepatocellular carcinoma.
El-Sherif WT; Makhlouf NA; El-Gendi SS; Hassan HI; Herdan OM
Egypt J Immunol; 2012; 19(2):53-65. PubMed ID: 23885407
[TBL] [Abstract][Full Text] [Related]
10. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
[TBL] [Abstract][Full Text] [Related]
11. Influence of VEGF-C936T genetic variant on age-related macular degeneration.
Gonçalves FT; Cezario SM; Calastri MC; Oliveira CI; Souza DR; Pinhel MA; Cotrim CC; Jorge R; Siqueira RC
Arq Bras Oftalmol; 2015; 78(5):290-4. PubMed ID: 26466227
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphism in the promoter region of human alpha-fetoprotein (AFP) gene and its significance in hepatocellular carcinoma (HCC).
Chen GG; Ho RL; Wong J; Lee KF; Lai PB
Eur J Surg Oncol; 2007 Sep; 33(7):882-6. PubMed ID: 17433605
[TBL] [Abstract][Full Text] [Related]
13. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S
Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996
[TBL] [Abstract][Full Text] [Related]
14. Development of a novel score for early detection of hepatocellular carcinoma among high-risk hepatitis C virus patients.
El-mezayen HA; Darwish H
Tumour Biol; 2014 Jul; 35(7):6501-9. PubMed ID: 24687551
[TBL] [Abstract][Full Text] [Related]
15. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
16. Association between single nucleotide polymorphisms in the cyclooxygenase-2, tumor necrosis factor-α, and vascular endothelial growth factor-A genes, and susceptibility to hepatocellular carcinoma.
Giacalone A; Montalto G; Giannitrapani L; Balasus D; Terranova A; Cervello M; Soresi M; Marasà L
OMICS; 2011 Mar; 15(3):193-6. PubMed ID: 21319995
[TBL] [Abstract][Full Text] [Related]
17. The role of vascular endothelial growth factor -634 G/C and its soluble receptor on chronic liver disease and hepatocellular carcinoma.
Ratnasari N; Nurdjanah S; Sadewa AH; Hakimi M
Arab J Gastroenterol; 2016 Jun; 17(2):61-6. PubMed ID: 27426958
[TBL] [Abstract][Full Text] [Related]
18. Alpha-fetoprotein gene polymorphisms and risk of HCC and cirrhosis.
Suriapranata IM; Sudania WM; Tjong WY; Suciptan AA; Gani RA; Hasan I; Sanityoso A; Budihusodo U; Miskad UA; Akil F; Lelosutan SA; Martamala R; Yusuf I; Lesmana LA; Sulaiman A; Tai S
Clin Chim Acta; 2010 Mar; 411(5-6):351-8. PubMed ID: 19968979
[TBL] [Abstract][Full Text] [Related]
19. Differential vascular endothelial growth factor A protein expression between small hepatocellular carcinoma and cirrhosis correlates with serum vascular endothelial growth factor A and alpha-fetoprotein.
Corradini SG; Morini S; Liguori F; Carotti S; Muda AO; Burza MA; Siciliano M; Molinaro A; Cantafora A; Blotta I; Merli M; Berloco P; Rossi M; Attili AF; Gaudio E
Liver Int; 2009 Jan; 29(1):103-12. PubMed ID: 18544126
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y
World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
